AIM ImmunoTech Inc. (AIM)
NYSE: AIM · Biological Products, (No Diagnostic Substances) · Ocala, FL · filing with the SEC since 1996
Who runs AIM ImmunoTech Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Equels Thomas K.
CEO & President. First filing Nov 2008, latest Nov 12, 2026, 57 filings in all.
Officers reporting now
1
of 2 people with a filing in the last fifteen months
Directors reporting now
1
13 people on the record since 2007
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Equels Thomas K. | CEO & President | Nov 2008 | Nov 12, 2026 | none |
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Chemerow David I. | director | Feb 2025 | Mar 16, 2026 | none |
Earlier names on the record11, newest filing first
Kellner Ted D · director · last filing Jul 2025Mitchell William M · director · last filing Apr 2025Rodino Peter W. III · officer · last filing Apr 2025Bryan Nancy · director · last filing Mar 2025Appelrouth Stewart · director · last filing Jan 2025Lintal Ellen M · officer · last filing Jan 2023Dickey Robert IV · officer · last filing Apr 2022Strayer David R · officer · last filing Jun 2019Springate Wayne S. · officer · last filing Jun 2019Pascale Adam · officer · last filing Jun 2019Kiani Iraj Eqhbal · director · last filing Jul 2016
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.